SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

MEDICAMEN BIOTECH

BSE: 531146 09 Sep 2025
Healthcare
₹ 346.3
Medicamen Biotech Ltd. specializes in Pharmaceuticals within the Healthcare sector.

MEDICAMEN BIOTECH - Share Price & Details

Market Cap
₹475.0
High /Low
630.0 / 340.0
Stock P/E
50.1
Book Value
₹167.0
Dividend Yield
0.29
ROCE
5.39
ROE
₹3.39
Face Value
10.0
PEG Ratio
-2.29
EVEBITDA
₹23.9
Debt
33.2
CMP / FCF
-40.6
Debt to equity
₹0.16
NP Ann
6.56
High price all time
1,225
Piotroski score
₹3.0
Graham Number
166.0
No. Eq. Shares
1.36
Net CF
₹-11.0
Net profit
7.28
Price to book value
2.08
Interest Coverage
₹3.9
Low price all time
4.75
Industry PE
33.1
Reserves
₹200
Free Cash Flow
₹-9.26

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
MEDICAMEN BIOTECH LTD.389.1916.37384.491.21475.050.1
ALBERT DAVID LTD.926.0379.38705.6613.9146073.1
OXYGENTA PHARMACEUTICAL LIMITENANANANA456

Peer Comparison Chart


About MEDICAMEN BIOTECH

Medicamen Biotech Ltd., with Security Code 531146, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Medicamen Biotech Faces Financial Challenges Amid Broader Market Trends and Declining Performance

(07 Sep 2025)
Medicamen Biotech has reached a new 52-week low, reflecting a broader underperformance in the Pharmaceuticals & Biotechnology sector.
Read more →

Medicamen Biotech Hits 52-Week Low Amid Broader Market Gains and Profitability Concerns

(05 Sep 2025)
Medicamen Biotech has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company is trading below...
Read more →

Medicamen Biotech Hits 52-Week Low Amid Declining Profit and Cash Reserves

(03 Sep 2025)
Medicamen Biotech has reached a new 52-week low, following a decline in its stock price. Despite this, the company has outperformed its sector slightly and...
Read more →

Medicamen Biotech Faces Continued Decline Amidst Long-Term Growth Challenges

(26 Aug 2025)
Medicamen Biotech has reached a new 52-week low, continuing a downward trend with a notable decline over the past three days.
Read more →

Medicamen Biotech AGM scheduled

(20 Aug 2025)
Medicamen Biotech announced that the 32th Annual General Meeting(AGM) of the company will be held on 26 September 2025. More News.
Read more →

Medicamen Biotech (NSE:MEDICAMEQ) Is Paying Out A Dividend Of ₹1.00

(15 Aug 2025)
Medicamen Biotech Limited ( NSE:MEDICAMEQ ) has announced that it will pay a dividend of ₹1.00 per share on the 26th of...
Read more →

Company Updates